These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 6997536)

  • 1. [Fundamental and clinical studies of sustained release cephalexin (L-Keflex) in the field of oral surgery (author's transl)].
    Morihana T; Ueda K; Muraoka M; Tsushima T; Kodama M; Nagata K; Nakao K; Shimada K
    Jpn J Antibiot; 1980 Apr; 33(4):514-21. PubMed ID: 6997536
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Double-blind comparison of L-keflex and cephalexin (Keflex) in dental infections (author's transl)].
    Horii M; Morinaga T; Shimada S; Takeuchi T; Yamanaka H; Nishimura T; Noshi Y; Okada T; Sasaki T; Ikeda S; Takada S; Iizuka O; Kimura J; Sagara S; Inada Y; Nishioka Y; Kimata M
    Jpn J Antibiot; 1980 Nov; 33(11):1194-214. PubMed ID: 7017189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical experience with sustained release cephalexin (S-6437) in pediatrics (author's transl)].
    Hori M; Okamoto K; Kohno S
    Jpn J Antibiot; 1978 Feb; 31(2):59-71. PubMed ID: 642208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Studies of sustained release cephalexin (S-6437) in pediatrics (author's transl)].
    Saito K; Ubukata K; Konno M
    Jpn J Antibiot; 1977 Sep; 30(9):672-6. PubMed ID: 916187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical experience with sustained release cefalexin (author's transl)].
    Takada K
    Jpn J Antibiot; 1977 Oct; 30(10):793-801. PubMed ID: 592481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical experience with sustained release cefalexin (S-6436) in surgery (author's transl)].
    Takenaka M; Tanimura H; Kamata T; Setoyama M
    Jpn J Antibiot; 1977 Nov; 30(11):893-7. PubMed ID: 592490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical experience with sustained release cephalexin (X-6437) (author's transl)].
    Kato R; Asano Y; Tsuzuki K; Iwayama S; Ito S
    Jpn J Antibiot; 1977 Nov; 30(11):888-92. PubMed ID: 592489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical and laboratory studies on S-6437 (a new longacting granule of cephalexin) in pediatric field (author's transl)].
    Kondo K; Kuno K; Koide T; Fukaya K; Jose H
    Jpn J Antibiot; 1977 Sep; 30(9):691-8. PubMed ID: 916190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical studies of S-6437 in pediatrics (author's transl)].
    Nishimura T; Kotani Y; Hiromatsu K; Takashima T; Asatani Y
    Jpn J Antibiot; 1977 Sep; 30(9):722-8. PubMed ID: 916193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinical experience with sustained release cefalexin (S-6437) for pediatric use in pediatrics (author's transl)].
    Hayashi M; Sugita K; Murata R; Fujii K
    Jpn J Antibiot; 1977 Nov; 30(11):881-7. PubMed ID: 592488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical evaluation of sustained release preparations of cefaclor in dental infections. Comparative double blind clinical studies of sustained release preparations with a regular preparation of cefaclor].
    Horii M; Shimada S; Yamanaka H; Nishimura T; Noshi Y; Okada T; Sasaki T; Inaba O; Takada S; Kimura J
    Jpn J Antibiot; 1985 Apr; 38(4):1117-40. PubMed ID: 3897614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical study of sustained release cephalexin (S-6436, S-6437) in dermatology (author's transl)].
    Okita K; Sato M; Hayakawa K; Kimura K
    Jpn J Antibiot; 1977 Nov; 30(11):911-5. PubMed ID: 592493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical experience with sustained release cephalexin (S-6436) in urology (author's transl)].
    Konya H; Kuroda J; Iwao N
    Jpn J Antibiot; 1977 Nov; 30(11):898-905. PubMed ID: 592491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Sustained release cephalexin (S-6436) and genitourinary tract infection (author's transl)].
    Furusawa T; Tanaka S
    Jpn J Antibiot; 1977 Oct; 30(10):806-18. PubMed ID: 592483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutical experience of cefadroxil against acute infectious diseases in the otorhinolaryngological field (author's transl)].
    Nagaba M
    Jpn J Antibiot; 1980 Mar; 33(3):253-5. PubMed ID: 7401306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bioavailability of new galenic preparations of cephalexin (author's transl)].
    Guggenbichler JP; Kienel G
    Padiatr Padol; 1978; 13(3):315-20. PubMed ID: 673437
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Laboratory and clinical studies on cefadroxil in the field of pediatrics (author's transl)].
    Iwai N; Sasaki A; Miyazu M; Osuga T
    Jpn J Antibiot; 1981 Jan; 34(1):77-94. PubMed ID: 7241809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical studies on cefadroxil in pediatrics (author's transl)].
    Terashima I; Nakamura A; Okimoto Y; Kurosaki T; Uehara S
    Jpn J Antibiot; 1981 Jan; 34(1):25-32. PubMed ID: 7017196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Study of S-6437, sustained release cephalexin, in pediatrics (author's transl)].
    Sato H; Fujii N; Shinnou K; Kojima S; Hirama Y
    Jpn J Antibiot; 1977 Sep; 30(9):684-90. PubMed ID: 916189
    [No Abstract]   [Full Text] [Related]  

  • 20. [Fundamental and clinical studies on cefadroxil dry syrup in children (author's transl)].
    Kobayashi Y; Morikawa Y; Haruta T; Fujiwara T
    Jpn J Antibiot; 1981 Jan; 34(1):33-40. PubMed ID: 7241805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.